Israel - English - Ministry of Health

mbi pharma ltd., israel - miglustat - hard capsule - miglustat 100 mg - miglustat - miglustat dipharma is indicated for the oral treatment of mild to moderate type i gaucher disease. miglustat dipharma may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable. miglustat dipharma is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with niemann-pick type c disease.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

sanofi-aventis south africa (pty) ltd - injection - see ingredients - each 10,0 ml liquid contains imiglucerase 400,0 units

Israel - English - Ministry of Health

a.l. medi-market ltd. - miglustat - capsules - miglustat 100 mg - miglustat - miglustat g.l. is indicated for the oral treatment of mild to moderate type i gaucher disease. miglustat g.l. may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable. miglustat g.l. is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with niemann-pick type c disease.